Financial Incentives to Address Representativeness in Randomized Clinical Trials

JAMA Internal Medicine · Published 2026-06-22 · DOI 10.1001/jamainternmed.2026.2507

Free full text

Authors (6)

Jamie S. Benson, Bhavik P. Patel, Brian Bayes, Elizabeth Cooney-Zingman, Alisa J. Stephens Shields, Scott D. Halpern

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Benson, J., Patel, B., Bayes, B., et al. (2026). Financial Incentives to Address Representativeness in Randomized Clinical Trials. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.2507

Related articles

• Potential Biases in Assessment of Smallest Worthwhile Difference for Statin Therapy—Reply · JAMA Internal Medicine · 2026 · Same journal
• An Indigenous Food Is Medicine Intervention · JAMA Internal Medicine · 2026 · Same journal
• Lessons From a Community-Designed Meal Program for Heart Failure · JAMA Internal Medicine · 2026 · Same journal
• Continuous Glucose Monitoring for Persons With and Without Diabetes · JAMA Internal Medicine · 2026 · Same journal
• Updated COVID-19 Vaccine Boosters—The Message From Data Is Consistent but Not Getting Through · JAMA Internal Medicine · 2026 · Same journal
• JAMA Internal Medicine · JAMA Internal Medicine · 2026 · Same journal
• Artificial Intelligence and the Financialization of Medical Knowledge · JAMA Internal Medicine · 2026 · Same journal
• When Risk Scores Meet Mammography—Navigating Supplemental Screening Decisions · JAMA Internal Medicine · 2026 · Same journal
• 2024-2025 COVID-19 Vaccine and Major Adverse Cardiovascular Events Among US Veterans · JAMA Internal Medicine · 2026 · Same journal
• Moral Injury—Report From Minnesota · JAMA Internal Medicine · 2026 · Same journal